Web Results
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.

en.wikipedia.org/wiki/Ebola_vaccine

Ebola vaccine candidates against Ebola have been developed in the decade prior to 2014, but none have yet been approved for clinical use in humans. Several promising vaccine candidates have been shown to protect nonhuman primates (usually macaques) against lethal infection. These include replication- deficient ...

www.linkedin.com/in/de-chu-christopher-tang-51351921

View De-chu Christopher Tang's profile on LinkedIn, the world's largest professional community. De-chu Christopher ... The Yin-Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation. Expert Rev. ... Founder. Vaxin Inc. December 1997 – Present (20 years 1 month)Birmingham, Alabama Area ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2778197

A long-sought goal during the battle against avian influenza is to develop a new generation of vaccines capable of mass immunizing humans as well as poultry ( the major source of avian influenza for human infections) in a timely manner. Although administration of the currently licensed influenza vaccine is effective in  ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4896786

Jul 21, 2014 ... When I established my own laboratory at University of Alabama at Birmingham ( UAB) in 1994, I challenged the contemporary method for vaccine ... the biotech company Vaxin Inc. on UAB campus with a focus on the development of skin patch vaccines which represented a cutting-edge technology at that ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4375354

Mar 26, 2015 ... AdVAV is a replication-deficient adenovirus type 5-vectored vaccine expressing the 83-kDa protective antigen (PA83) from Bacillus anthracis that is being developed for the prevention of disease caused by inhalation of aerosolized B. anthracis spores. A noninferiority study comparing the efficacy of AdVAV ...

academic.oup.com/ps/article-pdf/88/4/867/4441709/poultrysci88-0867.pdf

H. Toro *2 and D. C. Tang †. * Department of ... and † Vaxin Inc., 1500 First Avenue North, Birmingham, AL 35203. INTRODUCTION ... years, some of which have been reported to efficiently protect chickens against. HPAI (e.g., Swayne, 2003; Lee et al., 2004; Park et al., 2006). The distinct advantage of vectored vaccines.

academic.oup.com/ps/article/88/4/867/1557642

Apr 1, 2009 ... Highly pathogenic avian influenza (HPAI) viruses belonging to the H5 or H7 types continue to threaten the world poultry industry and are zoonotic agents with pandemic potential for humans (Ungchusak et al., 2005). Strategies to control avian influenza (AI) vary from none for low pathogenic AI virus strains ...

jvi.asm.org/content/75/23/11474.full

The TetC fragment was amplified by PCR from plasmid pTET-nir (2) (provided by J. VanCott and J. McGhee, University of Alabama at Birmingham) using the primers ... TetC (pCMV-tetC) was constructed by cloning the same TetC fragment into theBamHI site of the plasmid pVR1012 (provided by Vical, Inc., San Diego, Calif.) ...

www.tandfonline.com/doi/abs/10.1586/eri.12.76

Jan 10, 2014 ... Tau Hong Lee et al. Expert Review of Anti-infective Therapy. Published online: 27 Oct 2016. editorial. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection · Punnee Pitisuttithum et al. Expert Review of Vaccines. Published online: 16 Jun 2016.